Department of Medicine, Cardiovascular Section, University of Wisconsin, Madison, Wisconsin, USA.
Heart Rhythm. 2010 Jun;7(6):771-8. doi: 10.1016/j.hrthm.2010.01.032. Epub 2010 Feb 1.
Approximately 10% of sudden infant death syndrome (SIDS) cases may stem from potentially lethal cardiac channelopathies, with approximately half of channelopathic SIDS involving the Na(V)1.5 cardiac sodium channel. Recently, Na(V) beta subunits have been implicated in various cardiac arrhythmias. Thus, the 4 genes encoding Na(V) beta subunits represent plausible candidate genes for SIDS.
This study sought to determine the spectrum, prevalence, and functional consequences of sodium channel beta-subunit mutations in a SIDS cohort.
In this institutional review board-approved study, mutational analysis of the 4 beta-subunit genes, SCN1B to 4B, was performed using polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing of DNA derived from 292 SIDS cases. Engineered mutations were coexpressed with SCN5A in HEK 293 cells and were whole-cell patch clamped. One of the putative SIDS-associated mutations was similarly studied in adenovirally transduced adult rat ventricular myocytes.
Three rare (absent in 200 to 800 reference alleles) missense mutations (beta3-V36M, beta3-V54G, and beta4-S206L) were identified in 3 of 292 SIDS cases. Compared with SCN5A+beta3-WT, beta3-V36M significantly decreased peak I(Na) and increased late I(Na), whereas beta3-V54G resulted in a marked loss of function. beta4-S206L accentuated late I(Na) and positively shifted the midpoint of inactivation compared with SCN5A+beta4-WT. In native cardiomyocytes, beta4-S206L accentuated late I(Na) and increased the ventricular action potential duration compared with beta4-WT.
This study provides the first molecular and functional evidence to implicate the Na(V) beta subunits in SIDS pathogenesis. Altered Na(V)1.5 sodium channel function due to beta-subunit mutations may account for the molecular pathogenic mechanism underlying approximately 1% of SIDS cases.
大约 10%的婴儿猝死综合征(SIDS)病例可能源于潜在致命性的心脏通道病,其中大约一半的通道病 SIDS 涉及 Na(V)1.5 心脏钠离子通道。最近,Na(V)β亚基已被牵连到各种心律失常中。因此,编码 Na(V)β亚基的 4 个基因是 SIDS 的可能候选基因。
本研究旨在确定 SIDS 队列中钠离子通道β亚基突变的谱、流行率和功能后果。
在这项经机构审查委员会批准的研究中,使用聚合酶链反应、变性高效液相色谱和源自 292 例 SIDS 病例的 DNA 的直接 DNA 测序,对 4 个β亚基基因(SCN1B 至 4B)进行突变分析。将工程化突变与 SCN5A 在 HEK 293 细胞中共表达,并进行全细胞膜片钳记录。对一个假定的与 SIDS 相关的突变也在腺病毒转导的成年大鼠心室肌细胞中进行了类似的研究。
在 292 例 SIDS 病例中,发现了 3 个罕见的(在 200 至 800 个参考等位基因中缺失)错义突变(β3-V36M、β3-V54G 和 β4-S206L),分别出现在 3 例 SIDS 病例中。与 SCN5A+β3-WT 相比,β3-V36M 显著降低了峰值 I(Na)并增加了晚期 I(Na),而β3-V54G 导致明显的功能丧失。β4-S206L 与 SCN5A+β4-WT 相比,显著增加了晚期 I(Na)并正向移位失活的中点。在原代心肌细胞中,与β4-WT 相比,β4-S206L 显著增加了晚期 I(Na)并增加了心室动作电位持续时间。
本研究首次提供了分子和功能证据,表明 Na(V)β亚基参与了 SIDS 的发病机制。由于β亚基突变导致的 Na(V)1.5 钠离子通道功能改变可能解释了大约 1%的 SIDS 病例的分子发病机制。